SpIntellx ^Company

SpIntellx has the first-mover advantage in Precision Pathology and Spatially Intelligent Biology by applying truly unbiased spatial analytics software powered by explainable AI to decipher the complex cancer biology. SpIntellx’s software solutions have the potential to unlock a plethora of new applications in medicine and research by answering the fundamental question “Why?”, thus revealing the underlying patient-specific disease network biology, across each stage of the drug development, diagnostics, and treatment pipelines.